Esophageal cancer after sleeve gastrectomy: a population-based comparative cohort study

Background: Sleeve gastrectomy (SG) is the most common bariatric surgery; however, this approach may induce gastroesophageal reflux disease (GERD). Both obesity and GERD are independent risk factors for esophageal cancer, however the impact of SG on risk of esophageal cancer remains unknown. Objective: To evaluate the risk of esophageal cancer after reflux-prone bariatric surgery. Setting: Population-level, provincial administrative healthcare database, Quebec, Canada. Methods: We identified a population-based cohort of all patients with obesity who underwent refluxprone surgery (SG and duodenal switch [DS]) or reflux-protective Roux-en-Y gastric bypass (RYGB) during 01/2006-12/2012 in Quebec, Canada. For every surgical patient, 2-3 nonsurgical controls with obesity matched for age, sex, and geography were also identified. Crude incidence rate ratios (IRRs) for esophageal cancer were calculated using person-time analysis. Hazard ratios (HRs) were obtained using multivariate cox regression. Results: A total of 4121 patients had reflux-prone procedures and 852 underwent RYGB. At a mean follow-up of 7.6 years, 8 cases of esophageal cancer were identified after bariatric surgery. Compared with RYGB, IRR for esophageal cancer in reflux-prone group was 1.45 (95%CI:.19-65.5) and HR = .83 (95%CI:.10-7.27). The crude incidence rate of esophageal cancer in the reflux-prone group was higher than that of nonsurgical controls (n = 12,159; IRR = 3.46, 95%CI: 1.00-12.5), but after adjustment the difference disappeared (HR = 2.47, 95%CI:.82-7.45). Conclusions: Long-term incidence of esophageal cancer after reflux-prone bariatric surgery is not greater than RYGB. While crude incidence of esophageal cancer after reflux-prone surgery is higher than in nonsurgical patients with obesity, such difference disappears after accounting for confounders. Given the low incidence of esophageal cancer and slow progression of dysplastic Barrett esophagus, studies with longer follow-up are needed. (C) 2020 American Society for Bariatric Surgery. Published by Elsevier Inc. All rights reserved.

Automated summary

A study was conducted to evaluate the risk of esophageal cancer after reflux-prone bariatric surgery in obese patients. The incidence rate of esophageal cancer in the reflux-prone group was higher than in the nonsurgical controls, but the difference disappeared after adjustment for confounders. Long-term incidence of esophageal cancer after reflux-prone bariatric surgery was not greater than that of the reflux-protective RYGB.